X-153872575-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001278116.2(L1CAM):​c.197+17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00545 in 1,150,122 control chromosomes in the GnomAD database, including 162 homozygotes. There are 1,650 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 76 hom., 666 hem., cov: 23)
Exomes 𝑓: 0.0035 ( 86 hom. 984 hem. )

Consequence

L1CAM
NM_001278116.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.202

Publications

1 publications found
Variant links:
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
L1CAM Gene-Disease associations (from GenCC):
  • L1 syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked hydrocephalus with stenosis of the aqueduct of Sylvius
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • MASA syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • X-linked complicated corpus callosum dysgenesis
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • X-linked complicated spastic paraplegia type 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-153872575-C-T is Benign according to our data. Variant chrX-153872575-C-T is described in ClinVar as Benign. ClinVar VariationId is 92921.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0766 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
L1CAMNM_001278116.2 linkc.197+17G>A intron_variant Intron 4 of 28 ENST00000370060.7 NP_001265045.1
L1CAMNM_000425.5 linkc.197+17G>A intron_variant Intron 3 of 27 NP_000416.1
L1CAMNM_024003.3 linkc.197+17G>A intron_variant Intron 3 of 26 NP_076493.1
L1CAMNM_001143963.2 linkc.182+17G>A intron_variant Intron 2 of 25 NP_001137435.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
L1CAMENST00000370060.7 linkc.197+17G>A intron_variant Intron 4 of 28 5 NM_001278116.2 ENSP00000359077.1
ENSG00000284987ENST00000646191.1 linkn.*239+17G>A intron_variant Intron 4 of 4 ENSP00000493873.1

Frequencies

GnomAD3 genomes
AF:
0.0237
AC:
2636
AN:
111073
Hom.:
75
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0789
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00860
Gnomad ASJ
AF:
0.00757
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000390
Gnomad FIN
AF:
0.000165
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00155
Gnomad OTH
AF:
0.0251
GnomAD2 exomes
AF:
0.00748
AC:
1367
AN:
182710
AF XY:
0.00504
show subpopulations
Gnomad AFR exome
AF:
0.0812
Gnomad AMR exome
AF:
0.00456
Gnomad ASJ exome
AF:
0.00804
Gnomad EAS exome
AF:
0.0000722
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00116
Gnomad OTH exome
AF:
0.00309
GnomAD4 exome
AF:
0.00349
AC:
3621
AN:
1038991
Hom.:
86
Cov.:
26
AF XY:
0.00308
AC XY:
984
AN XY:
319661
show subpopulations
African (AFR)
AF:
0.0791
AC:
2002
AN:
25316
American (AMR)
AF:
0.00495
AC:
174
AN:
35130
Ashkenazi Jewish (ASJ)
AF:
0.00858
AC:
163
AN:
19008
East Asian (EAS)
AF:
0.000167
AC:
5
AN:
29988
South Asian (SAS)
AF:
0.000284
AC:
15
AN:
52824
European-Finnish (FIN)
AF:
0.000124
AC:
5
AN:
40464
Middle Eastern (MID)
AF:
0.00375
AC:
15
AN:
4005
European-Non Finnish (NFE)
AF:
0.00119
AC:
936
AN:
788069
Other (OTH)
AF:
0.00693
AC:
306
AN:
44187
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
135
270
405
540
675
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0239
AC:
2651
AN:
111131
Hom.:
76
Cov.:
23
AF XY:
0.0200
AC XY:
666
AN XY:
33367
show subpopulations
African (AFR)
AF:
0.0792
AC:
2420
AN:
30560
American (AMR)
AF:
0.00859
AC:
90
AN:
10474
Ashkenazi Jewish (ASJ)
AF:
0.00757
AC:
20
AN:
2642
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3495
South Asian (SAS)
AF:
0.000391
AC:
1
AN:
2555
European-Finnish (FIN)
AF:
0.000165
AC:
1
AN:
6065
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00155
AC:
82
AN:
52944
Other (OTH)
AF:
0.0247
AC:
37
AN:
1496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
88
176
263
351
439
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0139
Hom.:
75
Bravo
AF:
0.0269

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jul 01, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 01, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic paraplegia Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.19
DANN
Benign
0.30
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5987174; hg19: chrX-153138030; COSMIC: COSV62830249; COSMIC: COSV62830249; API